Deborah Moore
Nurse Practitioner · Greenville, SCNPI 1437131257
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.4% of the total across 559 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Teva Pharmaceuticals USA, Inc. at 29.1% of the total. Reporting peaked in 2022 at $2,969 and has fallen 52.6% since, to $1,408 in 2025. Among nurse practitioner clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 559 payments — averaging $20.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$3K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- AbbVie$1K
- Alkermes, Inc.$1K
- Otsuka America Pharmaceutical, Inc.$914
- Vanda Pharmaceuticals Inc.$730
- plus $3K from 16 others
What the payments were for
- Food & beverage$10,99494%
- Education$6516%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 176 | $3,389 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 52 | $1,571 |
| AbbVie(2 entities) | 72 | $1,059 |
| Alkermes, Inc. | 34 | $1,041 |
| Otsuka America Pharmaceutical, Inc. | 50 | $914 |
| Vanda Pharmaceuticals Inc. | 34 | $730 |
| Neurocrine Biosciences, Inc. | 42 | $645 |
| Axsome Therapeutics, Inc. | 9 | $562 |
| Johnson & Johnson | 36 | $548 |
| Sunovion Pharmaceuticals Inc. | 15 | $344 |
| E.r. Squibb & Sons, L.L.C. | 8 | $169 |
| Abbott | 1 | $151 |
| Indivior Inc. | 7 | $130 |
| Lundbeck LLC | 6 | $123 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $76 |
| Noven Therapeutics, LLC | 5 | $66 |
| Supernus Pharmaceuticals, Inc. | 3 | $39 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $28 |
| Corium, LLC | 1 | $23 |
| Tris Pharma Inc | 1 | $15 |
| Almatica Pharma LLC | 1 | $14 |
| Eisai Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AUSTEDO$571
- CAPLYTA$489
- ARISTADA$479
- LYBALVI$407
- Auvelity$367
- REXULTI$340
- VRAYLAR$231
- Austedo XR$226
- FREESTYLE LIBRE 3$151
- INVEGA SUSTENNA$122
- ARISTADA INITIO$120
- UZEDY$113
How this compares
$11,646 in reported general payments places this provider in the 95th percentile of 1,346 nurse practitioner providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 153 | $458,818 |
| AustedoDeutetrabenazine | 38 | $279,470 |
| IngrezzaValbenazine Tosylate | 27 | $226,368 |
| Abilify MaintenaAripiprazole | 73 | $216,509 |
| Austedo XrDeutetrabenazine | 22 | $172,640 |
| Invega TrinzaPaliperidone Palmitate | 14 | $147,828 |
| RexultiBrexpiprazole | 74 | $117,670 |
| Abilify AsimtufiiAripiprazole | 11 | $57,806 |
| CaplytaLumateperone Tosylate | 20 | $51,162 |
| VraylarCariprazine Hcl | 31 | $45,705 |
| FanaptIloperidone | 25 | $45,311 |
| Risperdal ConstaRisperidone Microspheres | 16 | $39,697 |
| AristadaAripiprazole Lauroxil | 11 | $26,969 |
| TrintellixVortioxetine Hydrobromide | 39 | $24,368 |
| LybalviOlanzapine/Samidorphan Malate | 11 | $17,155 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna, Invega Trinza, Risperdal Consta | $548 | $646,342183 claims |
| Teva Pharmaceuticals USA, Inc.Austedo, Austedo Xr | $3,389 | $452,11060 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti, Abilify Asimtufii | $914 | $391,985158 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $645 | $226,36827 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $1,571 | $51,16220 claims |
| AbbVieVraylar | $1,059 | $45,70531 claims |
| Vanda Pharmaceuticals Inc.Fanapt | $730 | $45,31125 claims |
| Alkermes, Inc.Aristada, Lybalvi | $1,041 | $44,12422 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $76 | $24,36839 claims |
| Axsome Therapeutics, Inc.Auvelity | $562 | $14,65112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,346 nurse practitioner providers in South Carolina.
Other nurse practitioner in Greenville
- David WiltGreenville$90K
- Mae BurtonGreenville$21K
- Cindy LoebGreenville$9K
- Ashley BurrissGreenville$8K
- Kristina AldrichGreenville$7K
- Whitney ReedCharleston$54K
- Mary JohnsonCharleston$34K
- Amanda HareCharleston$30K
- Kellie McLainCharleston$28K
- Colleen BoydSummerville$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.